MedPath

AZAZ KEARIEST CHEWABLE TABLET

Registration Number: MAL21026119N

Approved
Approval ID

2fdc4fa549b8ae4b

Registration Number

MAL21026119N

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types4 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (4)

15 TabletsAvailable
Package Size: 15 Tablets
Status: NPRA Approved
30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

DL-ALPHA TOCOPHERYL ACETATEActive
Phyllanthus emblica (Amla) Fruit ExtractActive
Monograph: phyllanthus emblica (amla) fruit extract
ASCORBIC ACID (VITAMIN C)Active
Monograph: ascorbic acid (vitamin c)
ZINC SULFATE MONOHYDRATEActive
Monograph: zinc sulfate monohydrate
D-BIOTINActive
Monograph: Biotin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AZAZ KEARIEST CHEWABLE TABLET - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform